Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-19

Clinical Trial Update: Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy of rotigotine on motor symptoms and apathy in Parkinson's disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rotigotine (rotigotine)

Snippet

Sponsor: UCB BIOSCIENCES GmbH | Conditions: Idiopathic Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-01-19